Award

Conract for provision of QIAsec Targeted DNA Custom panels & QIAsec 96-Index I Set A

THE ROYAL MARSDEN NHS FOUNDATION TRUSTS

This public procurement record has 1 release in its history.

Award

02 Apr 2019 at 12:30

Award Notice
Summary of the contracting process

The Royal Marsden Hospital NHS Foundation Trust is seeking suppliers for the contract titled "Contract for provision of QIAsec Targeted DNA Custom panels & QIAsec 96-Index I Set A". This procurement falls within the blood-testing reagents industry category and is located in London, United Kingdom. The procurement method is limited, with the tender period having ended on 1st April 2019. The contract will commence on 10th April 2019 and is set to run until 9th April 2023, with an overall budget of £2,000,000.

This tender offers significant opportunities for businesses specialising in molecular biology products, particularly those that can provide advanced DNA sequencing solutions. Companies experienced in the production of custom laboratory reagents and those with expertise in next-generation sequencing technologies would be well-suited to compete for this contract. The awarded supplier, Qiagen Ltd, has been selected for their capability to deliver the required custom panels and reagents, underscoring the value of innovation and technical proficiency in this sector.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Start Free Trial Book a Demo
All Features Pricing

Notice Information

Notice Title

Conract for provision of QIAsec Targeted DNA Custom panels & QIAsec 96-Index I Set A

Notice Description

The Royal Marsden Hospital NHS Foundation Trust needs to purchase QIAsec Targeted DNA custom panels & QIAsec 96-Index I Set A reagents for molecular biology applications. QIAseq Targeted DNA Panels enable sample-to-insight, targeted next-generation sequencing (NGS) of DNA. This highly optimized solution facilitates ultrasensitive variant detection using integrated unique molecular indices (UMIs) from cells, tissue and biofluids. The required amount of template for a single QIAseq Targeted sequencing reaction ranges from 10 to 40 ng for fresh DNA or 40 to 250 ng for FFPE DNA. The QIAseq Targeted DNA Panels have been developed as a complete Sample to Insight solution to enable digital DNA sequencing by utilizing molecular barcodes. Digital DNA sequencing is a unique approach to detect low-frequency variants with high confidence by overcoming the issues of PCR duplicates, false positives and library bias. Each panel is a one-box, NGS platform-agnostic solution that contains all the necessary components to construct libraries from enriched genomic targets. Primer design is based on single primer extension, in which each genomic target is enriched by one target-specific primer and a universal primer, a strategy that removes conventional two target-specific primer design restriction and reduces the amount of required primers. All primers required for a panel are pooled into an individual primer pool to reduce panel handling and number of pools required for enrichment and library construction. Platform-specific indexes, which are contained in a separate box, allow the multiplexing of up to 384 samples per sequencing run. The unique buffer and enzyme system used in the QIAseq targeted DNA panels has been optimized to achieve high coverage of GC-rich genomic regions. Custom panels can be designed to target exonic regions of genes, hotspots or SNPs, as well as intronic and promoter regions.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-62bab432-df34-45a5-83d3-2716837a1e2a
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/739385d6-89cf-4e2f-b1bc-51bc66f50b72
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award of contract without prior publication of a contract notice
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33696200 - Blood-testing reagents

Notice Value(s)

Tender Value
£2,000,000 £1M-£10M
Lots Value
Not specified
Awards Value
£1,800,000 £1M-£10M
Contracts Value
Not specified

Notice Dates

Publication Date
2 Apr 20196 years ago
Submission Deadline
1 Apr 2019Expired
Future Notice Date
Not specified
Award Date
1 Apr 20196 years ago
Contract Period
9 Apr 2019 - 9 Apr 2023 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
THE ROYAL MARSDEN NHS FOUNDATION TRUSTS
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SW10 0XD
Post Town
South West London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI3 Inner London - West
Small Region (ITL 3)
TLI33 Kensington & Chelsea and Hammersmith & Fulham
Delivery Location
TLI London
Local Authority
Hammersmith and Fulham
Electoral Ward
Sands End
Westminster Constituency
Chelsea and Fulham

Supplier Information

Number of Suppliers
1
Supplier Name

QIAGEN

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts. 

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-b5fd17-62bab432-df34-45a5-83d3-2716837a1e2a-2019-04-02T13:30:31+01:00",
    "date": "2019-04-02T13:30:31+01:00",
    "ocid": "ocds-b5fd17-62bab432-df34-45a5-83d3-2716837a1e2a",
    "language": "en",
    "initiationType": "tender",
    "tender": {
        "id": "CHELWEST-DN398114-21575509",
        "title": "Conract for provision of QIAsec Targeted DNA Custom panels & QIAsec 96-Index I Set A",
        "description": "The Royal Marsden Hospital NHS Foundation Trust needs to purchase QIAsec Targeted DNA custom panels & QIAsec 96-Index I Set A reagents for molecular biology applications. QIAseq Targeted DNA Panels enable sample-to-insight, targeted next-generation sequencing (NGS) of DNA. This highly optimized solution facilitates ultrasensitive variant detection using integrated unique molecular indices (UMIs) from cells, tissue and biofluids. The required amount of template for a single QIAseq Targeted sequencing reaction ranges from 10 to 40 ng for fresh DNA or 40 to 250 ng for FFPE DNA. The QIAseq Targeted DNA Panels have been developed as a complete Sample to Insight solution to enable digital DNA sequencing by utilizing molecular barcodes. Digital DNA sequencing is a unique approach to detect low-frequency variants with high confidence by overcoming the issues of PCR duplicates, false positives and library bias. Each panel is a one-box, NGS platform-agnostic solution that contains all the necessary components to construct libraries from enriched genomic targets. Primer design is based on single primer extension, in which each genomic target is enriched by one target-specific primer and a universal primer, a strategy that removes conventional two target-specific primer design restriction and reduces the amount of required primers. All primers required for a panel are pooled into an individual primer pool to reduce panel handling and number of pools required for enrichment and library construction. Platform-specific indexes, which are contained in a separate box, allow the multiplexing of up to 384 samples per sequencing run. The unique buffer and enzyme system used in the QIAseq targeted DNA panels has been optimized to achieve high coverage of GC-rich genomic regions. Custom panels can be designed to target exonic regions of genes, hotspots or SNPs, as well as intronic and promoter regions.",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33696200",
            "description": "Blood-testing reagents"
        },
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "London",
                        "countryName": "United Kingdom"
                    }
                ]
            }
        ],
        "value": {
            "amount": 2000000,
            "currency": "GBP"
        },
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award of contract without prior publication of a contract notice",
        "tenderPeriod": {
            "endDate": "2019-04-01T23:59:59+01:00"
        },
        "contractPeriod": {
            "startDate": "2019-04-10T00:00:00+01:00",
            "endDate": "2023-04-09T23:59:59+01:00"
        },
        "suitability": {
            "sme": false,
            "vcse": false
        },
        "mainProcurementCategory": "goods"
    },
    "parties": [
        {
            "id": "GB-CFS-94986",
            "name": "The Royal Marsden NHS Foundation Trusts",
            "identifier": {
                "legalName": "The Royal Marsden NHS Foundation Trusts"
            },
            "address": {
                "streetAddress": "Unit G3, Harbour Yard, Chelsea Harbour",
                "locality": "London",
                "postalCode": "SW10 0XD",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "tenders@chelwest.nhs.uk"
            },
            "roles": [
                "buyer"
            ]
        },
        {
            "id": "GB-CFS-39674",
            "name": "Qiagen Ltd",
            "identifier": {
                "legalName": "Qiagen Ltd"
            },
            "address": {
                "streetAddress": "Skelton House, Lloyd Street North, Manchester, M15 6SH"
            },
            "details": {
                "scale": "large",
                "vcse": false
            },
            "roles": [
                "supplier"
            ]
        }
    ],
    "buyer": {
        "id": "GB-CFS-94986",
        "name": "The Royal Marsden NHS Foundation Trusts"
    },
    "awards": [
        {
            "id": "ocds-b5fd17-62bab432-df34-45a5-83d3-2716837a1e2a-1",
            "status": "active",
            "date": "2019-04-02T00:00:00+01:00",
            "datePublished": "2019-04-02T13:30:31+01:00",
            "value": {
                "amount": 1800000,
                "currency": "GBP"
            },
            "suppliers": [
                {
                    "id": "GB-CFS-39674",
                    "name": "Qiagen Ltd"
                }
            ],
            "contractPeriod": {
                "startDate": "2019-04-10T00:00:00+01:00",
                "endDate": "2023-04-09T23:59:59+01:00"
            },
            "documents": [
                {
                    "id": "1",
                    "documentType": "awardNotice",
                    "description": "Awarded contract notice on Contracts Finder",
                    "url": "https://www.contractsfinder.service.gov.uk/Notice/739385d6-89cf-4e2f-b1bc-51bc66f50b72",
                    "datePublished": "2019-04-02T13:30:31+01:00",
                    "format": "text/html",
                    "language": "en"
                }
            ]
        }
    ]
}